Literature DB >> 3921147

Extracorporeal shock wave lithotripsy: the first 50 patients treated in Britain.

J E Wickham, D R Webb, S R Payne, M J Kellet, G Watkinson, H N Whitfield.   

Abstract

Fifty patients have been treated for upper tract urinary calculi by extracorporeal shock wave lithotripsy (ESWL) at the Devonshire Hospital lithotripter centre since November 1984. The average stay for an inpatient was 3 X 7 days. All patients suffered minimal postoperative discomfort and nearly all resumed normal activity within one day after discharge. Complications requiring auxiliary procedures were few. The procedure was found to be safe, cost effective, extremely well received by patients, and superior to all other methods of removing renal stones. This study confirms that treatment by ESWL is a specialised urological procedure that requires operators who are also trained in open, percutaneous, and ureteroscopic surgery and with a back up of a radiological team skilled in percutaneous renal puncture.

Entities:  

Mesh:

Year:  1985        PMID: 3921147      PMCID: PMC1418862          DOI: 10.1136/bmj.290.6476.1188

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

1.  Epidemiology of renal stones in a middle-aged male population.

Authors:  S Ljunghall; H Hedstrand
Journal:  Acta Med Scand       Date:  1975-06

2.  Financial analysis, personnel planning and organizational requirements for the installation of a kidney lithotripter in a urologic department.

Authors:  K Miller; G Fuchs; J Rassweiler; F Eisenberger
Journal:  Eur Urol       Date:  1984       Impact factor: 20.096

3.  The prevalence of calcified upper urinary tract stone disease in a random population--Cumbernauld Health Survey.

Authors:  R Scott; R Freeland; W Mowat; M Gardiner; V Hawthorne; R M Marshall; J G Ives
Journal:  Br J Urol       Date:  1977

4.  Extracorporeally induced destruction of kidney stones by shock waves.

Authors:  C Chaussy; W Brendel; E Schmiedt
Journal:  Lancet       Date:  1980-12-13       Impact factor: 79.321

  4 in total
  12 in total

1.  Treatment of radiolucent renal calculi using ESWL combined with urine alkalinization.

Authors:  M I Ezzat
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  The randomised controlled trial in the evaluation of new technology: a case study.

Authors:  S Challah; N B Mays
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-29

Review 3.  Review of general surgery 1985.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

4.  Blood cellular and biochemical changes after extracorporeal shock wave lithotripsy.

Authors:  F Di Silverio; M Gallucci; P Gambardella; G Alpi; R Benedetti; R La Mancusa; F M Pulcinelli; R Romiti; P P Gazzaniga
Journal:  Urol Res       Date:  1990

5.  The effects of extracorporeal shock wave lithotripsy on urological prostheses and endoprostheses.

Authors:  T A McNicholas; J W Ramsay; P R Crocker; D R Webb; J E Wickham
Journal:  Urol Res       Date:  1986

Review 6.  Role of endoscopic surgery in management of renal and ureteric calculi: a review.

Authors:  R A Miller
Journal:  J R Soc Med       Date:  1985-12       Impact factor: 5.344

7.  One hundred cases of anaesthesia for extracorporeal shock wave lithotripsy.

Authors:  M Frank; E J McAteer; D G Cohen; I J Blair
Journal:  Ann R Coll Surg Engl       Date:  1985-11       Impact factor: 1.891

8.  Extracorporeal shockwave lithotripsy: first 1000 cases at the London Stone Clinic.

Authors:  G Das; J Dick; M J Bailey; M S Fletcher; D R Webb; M J Kellett; H N Whitfield; J E Wickham
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

9.  The patients perspective of extracorporeal shock wave lithotripsy.

Authors:  N Mahmood; W Turner; K Rowgaski; D Almond
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

10.  Piezoelectric lithotripsy and soft tissue injury. Safety limits in the experimental and clinical setting.

Authors:  A Darzi; I Reid; E Kay; J R Monson; W A Tanner; F B Keane
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.